Decision-Supported Collaborative Care for Gestational Diabetes: A Narrative Review of Development Pathways and Evaluation in Routine Clinical Practice
Related Experiment Videos
Yan Yan1, Maoguang Yang1, Lijuan Wang1
1Department of Endocrinology, The Second Hospital of Jilin University, Changchun, 130000, People's Republic of China.
Abstract:
Gestational diabetes mellitus (GDM) requires frequent glucose monitoring, rapid behavior adjustment, and timely escalation within a short pregnancy window, yet routine care is often episodic and fragmented across teams. Digital tools have improved data capture, but many systems still stop at logging and messaging and do not consistently translate patient-generated data into clinical action. This review frames decision-supported collaborative care for GDM as a workflow-centered care model that links glucose and clinical context to interpretable decision logic and role-based team processes for triage, escalation, and closed-loop feedback. We conducted a structured narrative review of English-language studies indexed in PubMed/MEDLINE and Web of Science from database inception to 2026, supplemented by manual screening of relevant reference lists. Owing to substantial heterogeneity in intervention design, clinical settings, and reported outcomes, the evidence was synthesized narratively. We summarize key system components, outline a practical development pathway from defining actionable use cases to embedding safety guardrails and workflow integration, and propose a multidimensional evaluation approach that combines clinical outcomes with process, implementation, and system-level measures. We also discuss major barriers to scale, including alert burden, role accountability, data governance and privacy, and digital equity. This framework may support clinicians, healthcare organizations, and policymakers in designing, implementing, and evaluating safe, equitable, and workflow-compatible GDM services.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Introduction